EUVIMEDEUVIMED entdecken
Crossref

Response Evaluation Criteria for Neuroendocrine Tumor Lesions on Somatostatin Receptor PET/CT after Peptide Receptor Radionuclide Therapy

A. Chaban, Y. Song, V. Dinkel, M. Eiber, J. Brosch-Lenz, S. Krebs, L. Bodei, W. Weber

Nuklearmedizin - NuclearMedicine · 01.03.2024 · 63 (02) · 145

DOI: 10.1055/s-0044-1782446 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nuklearmedizin - NuclearMedicine, erschienen am 01.03.2024. Verfasst von A. Chaban und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Chaban, A., Song, Y., Dinkel, V., Eiber, M., Brosch-Lenz, J., Krebs, S., Bodei, L., & Weber, W. (2024). Response Evaluation Criteria for Neuroendocrine Tumor Lesions on Somatostatin Receptor PET/CT after Peptide Receptor Radionuclide Therapy. Nuklearmedizin - NuclearMedicine, 63(02), 145. https://doi.org/10.1055/s-0044-1782446

Vancouver

Chaban A, Song Y, Dinkel V, Eiber M, Brosch-Lenz J, Krebs S, et al. Response Evaluation Criteria for Neuroendocrine Tumor Lesions on Somatostatin Receptor PET/CT after Peptide Receptor Radionuclide Therapy. Nuklearmedizin - NuclearMedicine. 2024;63(02):145. doi:10.1055/s-0044-1782446

BibTeX
@article{Chaban2024,
  author = {Chaban, A. and Song, Y. and Dinkel, V. and Eiber, M. and Brosch-Lenz, J. and Krebs, S. and Bodei, L. and Weber, W.},
  title = {Response Evaluation Criteria for Neuroendocrine Tumor Lesions on Somatostatin Receptor PET/CT after Peptide Receptor Radionuclide Therapy},
  journal = {Nuklearmedizin - NuclearMedicine},
  year = {2024},
  volume = {63},
  number = {02},
  pages = {145},
  doi = {10.1055/s-0044-1782446}
}
Kostenlos starten →